- A study of African Americans in Mississippi shows an association between experiencing discrimination over a lifetime and developing hypertension (also referred to as high blood pressure).
- African Americans who reported medium and high levels of lifetime discrimination, compared to those who reported low lifetime discrimination, had a higher risk for hypertension.
Embargoed until 4 a.m. CT/5 a.m. ET July 1, 2020
DALLAS, July 1, 2020 — Lifetime discrimination is a chronic stressor that may increase the risk for hypertension also known as high blood pressure, in African Americans, according to new research published today in Hypertension, an American Heart Association journal.
“Previous studies have shown that discrimination affects African Americans’ health; however, this research is one of the first large, community-based studies to suggest an association between discrimination over a lifetime and the development of hypertension among a large sample of African American men and women,” said Allana T. Forde, Ph.D., M.P.H., the study’s first author and a postdoctoral research fellow at the Urban Health Collaborative at Drexel University in Philadelphia, Pennsylvania.
“African Americans continue to be disproportionately affected by hypertension, making it imperative to identify the drivers of hypertension in this population,” Forde said. “Greater lifetime discrimination was associated with an increased risk for hypertension among African Americans in this study, which reflects the impact of cumulative exposure to stressors over one’s lifetime and the physiological reactions to stress that contribute to deleterious health outcomes.”
Researchers reviewed data on 1,845 African Americans, ages 21 to 85, enrolled in The Jackson Heart Study, which focused on cardiovascular disease among African Americans in the tri-county areas of Jackson, Mississippi. The study participants did not have hypertension during the first visit in 2000 through 2004. Patients completed two follow-up study visits: one in 2005 through 2008, and the second between 2009 through 2013. Participants self-reported their discrimination experiences through in-home interviews, questionnaires and in-clinic examinations.
Participants were defined as having hypertension if they said they were taking blood pressure-lowering medication, or had a systolic blood pressure of 140 mm Hg or above or diastolic blood pressure higher than 90 mm Hg at follow-up visits.
During the follow-up period, more than half of the participants (954 or 52%) developed hypertension. Participants who reported medium levels compared to low levels of lifetime discrimination had a 49% increased risk for hypertension after accounting for other risk factors.
“The study has important implications for patient care and population health,” Forde said. “Traditional risk factors, such as diet and physical activity, have been strongly correlated with hypertension, yet important psychosocial factors like discrimination, which also have the potential to negatively impact health, are rarely considered when evaluating the risk for hypertension among African Americans in health care settings.”
“Our findings highlight the need for health care professionals to recognize discrimination as a social determinant of health. Health care professionals who understand the importance of unique stressors like discrimination that impact the health of African Americans will be better equipped to provide optimal patient care to this population.”
“However, medical care is not enough. More broadly, our results suggest how social determinants such as racism and discrimination affect health in measurable ways. Addressing these factors is critical to reducing rates of chronic diseases.”
The researchers note that although the study included experiences of discrimination among a large sample of African Americans, discrimination was measured at a single point in time, which limited the researchers’ ability to capture changes in discrimination experiences over the entire follow-up period.
Researchers said additional studies with African Americans in other regions of the U.S. are warranted to confirm the findings of this study. However, these results add to a large body of work documenting the impact of discrimination on the health of African Americans. Strategies to reduce health inequities and improve health are needed to address these broader social determinants.
Co-authors are Mario Sims, Ph.D., M.S.; Paul Muntner, Ph.D., M.H.S.; Tené Lewis, Ph.D.; Amanda Onwuka, Ph.D., M.P.H.; Kari Moore, M.S.; and Ana V. Diez Roux, M.D., Ph.D., M.P.H.
The Jackson Heart Study was supported by Jackson State University; Tougaloo College; the Mississippi State Department of Health; the University of Mississippi Medical Center; the National Heart, Lung, and Blood Institute and the National Institute for Minority Health and Health Disparities of the National Institutes of Health; and the American Heart Association.
- Available multimedia is on right column of release link https://newsroom.heart.org/news/lifetime-discrimination-may-increase-risk-of-hypertension-among-african-americans?preview=4301474cae5ae7991701ea73d3f3697a
- After July 1, 2020, view the manuscript online.
- High Blood Pressure and African Americans
- Target BP
- Check, Change, Control
- What does the life – and death – of George Floyd, Breonna Taylor and Ahmaud Arbery mean for the health of Blacks in America?
- Racial bias and discrimination may negatively impact heart disease care, risk factors
- Joint statement on health equity, social justice and civil unrest from the Association of Black Cardiologists, the American Heart Association and the American College of Cardiology
- Follow AHA/ASA news on Twitter @HeartNews
- Follow news from the Hypertension journal @HyperAHA
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Bridgette McNeill: email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)